drugset / Trial / NCT04530448

Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization

NCT04530448

Phase 4 Terminated 3 enrolled West Virginia University
RandomizedParallel-groupOpen-labelTreatment

Summary

Our overarching goal is to improve the outcomes of critically ill COVID-19 patients with or at risk for development of acute kidney injury (AKI). The objective of this study is to determine the role of a protocol to manage urine alkalization using a simple medication that has been used for a very long time, is safe, and without significant side-effects. We aim to determine the feasibility and safety of a urine alkalinization protocol for the prevention of AKI in patients testing positive for COVID-19.

Timeline

Start
2020-10-05
Primary completion
2021-07-15
Completion
2021-07-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium bicarbonate Diagnostic / imaging agent 225 meq Intravenous